4893 items matching your search terms.

Regarding Shikama et al. IJROBP 1999;44;991-6 [letter]

Foroudi, F Gebski, V Ahern, V

A prospective randomised trial of misoprostol for radiation mucositis

Foroudi, F. Timms, I. Veness, M. J. Gebski, V. Tiver, K.W.

Improving the interpretation of clinical studies using clinical significance curves

Gebski, V. J.; Shakespeare, T. P.; Veness, M. J.; Simes, R.J.

Progress in managing data accumulation

Ghersi, D.

What is a systematic review?

Ghersi, D.

Funding Cochrane activities in Australia

Ghersi, D.

The Cochrane Collaboration and the Cochrane Breast Cancer Group

Ghersi, D.

The educational and professional development needs of data managers in Australia

Ghersi, D. Beller, E.

Prospective meta-analysis: a practical guide

Ghersi, D. Berlin, J.A.

Methods for analysis of multiple events in the presence of death

Ghosh, D
CONTROLLED CLINICAL TRIALS, 2000     DOI:doi:10.1016/S0197-2456(00)00043-X

Nonparametric analysis of recurrent events and death

Ghosh, D Lin, D
BIOMETRICS, 2000     DOI:doi:10.1111/j.0006-341X.2000.00554.x

Phase II study of mitoxantrone, carboplatin and prednisolone in patients with hormone refractory prostate cancer

Gurney, H. Boyer, M. Millward, M. Wheeler, H. Underhill, C. Toner, G. Stockler, M. Sullivan, A.

Baseline risk factors and coronary heart disease outcomes among women in the LIPID study

Hague, W.; Johns, J.; Young, P.; Simes, J.; Tonkin A, ; on behalf of the LIPID study investigators,

Baseline risk factors and coronary heart disease outcomes among women in the LIPID study

Hague, W; Young, P; Johns, J; Simes, J; Tonkin, A; on behalf of the LIPID study investigators,

Randomised trial of Vaccinia melanoma cell lysates for high-risk stage II and III melanoma

Hersey, P Coates, A et al.